Tumor type | Clinical characteristic | Â | N (%) |
---|---|---|---|
Liver hepatocellular carcinoma (LIHC) | Age (years) |  > 65 | 36 (22.78) |
 |  |  ≤ 65 | 122 (77.22) |
 | Gender | Male | 124 (78.48) |
 |  | Female | 34 (21.52) |
 | Stage | I–II stage | 151 (95.57) |
 |  | III–IV stage | 7 (4.43) |
 | Vital status | Alive | 114 (72.15) |
 |  | Dead | 44 (27.85) |
Stomach adenocarcinoma (STAD) | Age (years) |  > 65 | 41 (55.41) |
 |  |  ≤ 65 | 33 (44.59) |
 | Gender | Male | 49 (66.22) |
 |  | Female | 25 (33.78) |
 | Stage | I- II stage | 43 (58.11) |
 |  | III–IV stage | 29 (39.19) |
 |  | Not reported | 2 (2.70) |
 | Vital status | Alive | 54 (72.97) |
 |  | Dead | 19 (25.68) |
 |  | Not reported | 1 (1.35) |
Esophageal carcinoma (ESCA) | Age (years) |  > 65 | 6 (15.79) |
 |  |  ≤ 65 | 32 (84.21) |
 | Gender | Male | 35 (92.11) |
 |  | Female | 3 (7.89) |
 | Stage | I–II stage | 11 (28.95) |
 |  | III–IV stage | 6 (15.79) |
 |  | Not reported | 21 (55.26) |
 | Vital status | Alive | 31 (81.58) |
 |  | Dead | 7 (18.42) |
Pancreatic adenocarcinoma (PAAD) | Age (years) |  > 65 | 4 (36.36) |
 |  |  ≤ 65 | 7 (63.64) |
 | Gender | Male | 5 (45.45) |
 |  | Female | 6 (54.55) |
 | Stage | I–II stage | 11 (100.00) |
 |  | III–IV stage | 0 (0.00) |
 | Vital status | Alive | 6 (54.55) |
 |  | Dead | 5 (45.45) |
Colon adenocarcinoma (COAD) | Age (years) |  > 65 | 2 (18.18) |
 |  |  ≤ 65 | 9 (81.82) |
 | Gender | Male | 8 (72.73) |
 |  | Female | 3 (27.27) |
 | Stage | I–II stage | 10 (90.91) |
 |  | III–IV stage | 1 (9.09) |
 | Vital status | Alive | 9 (81.82) |
 |  | Dead | 2 (18.18) |
Cholangiocarcinoma (CHOL) | Age (years) |  > 65 | 2 (66.67) |
 |  |  ≤ 65 | 1 (33.33) |
 | Gender | Male | 2 (66.67) |
 |  | Female | 1 (33.33) |
 | Stage | I–II stage | 3 (100.00) |
 |  | III–IV stage | 0 (0.00) |
 | Vital status | Alive | 1 (33.33) |
 |  | Dead | 2 (66.67) |
Rectum adenocarcinoma (READ) | Age (years) |  > 65 | 0 (0.00) |
 |  |  ≤ 65 | 1 (100.00) |
 | Gender | Male | 1 (100.00) |
 |  | Female | 0 (0.00) |
 | Stage | I–II stage | 1 (100.00) |
 |  | III–IV stage | 0 (0.00) |
 | Vital status | Alive | 1 (100.00) |
 |  | Dead | 0 (0.00) |